学术任务

日期 时间 会场 类型 Session/单元 题目
2025-06-14 17:00-17:08 分会场十(【B座-5层-501C】) 专题发言 Session V 风华正茂 锐意进取 Enfortumab Vedotin Plus Pembrolizumab (EV+P) Vs Chemotherapy (Chemo) in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC): Pan-Asian Subgroup Analysis From EV-302/KEYNOTE-A39